Literature DB >> 32432959

Emerging roles of long non-coding RNAs in the p53 network.

Abhinav K Jain1.   

Abstract

Transcription factor p53 is activated in response to numerous stress stimuli in order to promote repair and survival or death of abnormal cells. For decades, regulatory mechanisms and downstream targets that execute the many biological functions of tumour suppressor p53 largely focused on the products of protein-coding genes. Recently, an entirely new class of molecules, termed long non-coding RNAs (lncRNAs), were discovered as key regulatory players in shaping p53 activity and biological outcomes. Many p53-regulated lncRNAs are now reported to either directly or indirectly intervene in p53-regulatory networks, generally in fine-tuning p53's tumour surveillance programme. Recent studies reveal that signals that converge upon p53 to regulate its activity, and molecules that implement downstream p53-response include both proteins and lncRNAs. In this review, we discuss the non-proteomic component of p53-regulatory networks, focusing on lncRNAs regulated by p53 and/or that regulate p53 activity, and their impact on biological outcomes.

Entities:  

Keywords:  LncRNA; P53; cancer; long non-coding RNA; ncRNA; non-coding RNA; transcription factor; tumour suppressor

Year:  2020        PMID: 32432959      PMCID: PMC7567491          DOI: 10.1080/15476286.2020.1770981

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  86 in total

Review 1.  Making sense of ubiquitin ligases that regulate p53.

Authors:  Abhinav K Jain; Michelle Craig Barton
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

2.  Long Noncoding RNA PURPL Suppresses Basal p53 Levels and Promotes Tumorigenicity in Colorectal Cancer.

Authors:  Xiao Ling Li; Murugan Subramanian; Matthew F Jones; Ritu Chaudhary; Deepak K Singh; Xinying Zong; Berkley Gryder; Sivasish Sindri; Min Mo; Aaron Schetter; Xinyu Wen; Swetha Parvathaneni; Dickran Kazandjian; Lisa M Jenkins; Wei Tang; Fathi Elloumi; Jennifer L Martindale; Maite Huarte; Yuelin Zhu; Ana I Robles; Susan M Frier; Frank Rigo; Maggie Cam; Stefan Ambs; Sudha Sharma; Curtis C Harris; Mary Dasso; Kannanganattu V Prasanth; Ashish Lal
Journal:  Cell Rep       Date:  2017-09-05       Impact factor: 9.423

3.  A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response.

Authors:  C A Melo; N Léveillé; K Rooijers; P J Wijchers; G Geeven; A Tal; S A Melo; W de Laat; R Agami
Journal:  Oncogene       Date:  2016-01-18       Impact factor: 9.867

4.  Activation of p53 by MEG3 non-coding RNA.

Authors:  Yunli Zhou; Ying Zhong; Yingying Wang; Xun Zhang; Dalia L Batista; Roger Gejman; Peter J Ansell; Jing Zhao; Catherine Weng; Anne Klibanski
Journal:  J Biol Chem       Date:  2007-06-13       Impact factor: 5.157

5.  LincRNA-p21 activates p21 in cis to promote Polycomb target gene expression and to enforce the G1/S checkpoint.

Authors:  Nadya Dimitrova; Jesse R Zamudio; Robyn M Jong; Dylan Soukup; Rebecca Resnick; Kavitha Sarma; Amanda J Ward; Arjun Raj; Jeannie T Lee; Phillip A Sharp; Tyler Jacks
Journal:  Mol Cell       Date:  2014-05-22       Impact factor: 17.970

6.  Pint lincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2.

Authors:  Oskar Marín-Béjar; Francesco P Marchese; Alejandro Athie; Yolanda Sánchez; Jovanna González; Victor Segura; Lulu Huang; Isabel Moreno; Alfons Navarro; Mariano Monzó; Jesús García-Foncillas; John L Rinn; Shuling Guo; Maite Huarte
Journal:  Genome Biol       Date:  2013       Impact factor: 13.583

Review 7.  Mechanisms of transcriptional regulation by p53.

Authors:  Kelly D Sullivan; Matthew D Galbraith; Zdenek Andrysik; Joaquin M Espinosa
Journal:  Cell Death Differ       Date:  2017-11-10       Impact factor: 15.828

Review 8.  Targeting Oncogenic Mutant p53 for Cancer Therapy.

Authors:  Alejandro Parrales; Tomoo Iwakuma
Journal:  Front Oncol       Date:  2015-12-21       Impact factor: 6.244

9.  A negative regulation loop of long noncoding RNA HOTAIR and p53 in non-small-cell lung cancer.

Authors:  Nailiang Zhai; Yongfu Xia; Rui Yin; Jinping Liu; Fuquan Gao
Journal:  Onco Targets Ther       Date:  2016-09-16       Impact factor: 4.147

10.  The human lncRNA LINC-PINT inhibits tumor cell invasion through a highly conserved sequence element.

Authors:  Oskar Marín-Béjar; Aina M Mas; Jovanna González; Dannys Martinez; Alejandro Athie; Xabier Morales; Mikel Galduroz; Ivan Raimondi; Elena Grossi; Shuling Guo; Ana Rouzaut; Igor Ulitsky; Maite Huarte
Journal:  Genome Biol       Date:  2017-10-27       Impact factor: 13.583

View more
  3 in total

1.  Up regulation of long non-coding RNAs BACE1 and down regulation of LINC-PINT are associated with CRC clinicopathological characteristics.

Authors:  Sara Bakhtiari-Nezhad; Leili Rejali; Mahrooyeh Hadizadeh; Mohammad Yaghob Taleghani; Hamid Asadzadeh Aghdaei; Chris Young; Binazir Khanabadi; Ehsan Nazemalhosseini-Mojarad; Maziar Ashrafian Bonab
Journal:  Mol Biol Rep       Date:  2022-09-10       Impact factor: 2.742

2.  p53-Induced LINC00893 Regulates RBFOX2 Stability to Suppress Gastric Cancer Progression.

Authors:  Xinde Ou; Xingyu Zhou; Jin Li; Jinning Ye; Haohan Liu; Deliang Fang; Qinbo Cai; Shirong Cai; Yulong He; Jianbo Xu
Journal:  Front Cell Dev Biol       Date:  2022-01-19

Review 3.  Li-Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment.

Authors:  Valentina Rocca; Giovanni Blandino; Lucia D'Antona; Rodolfo Iuliano; Silvia Di Agostino
Journal:  Cancers (Basel)       Date:  2022-07-27       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.